Poor mental health leads to unhealthy behaviors in low-income adults – not the other way around, according to a new study¹ by Dr. Jennifer Walsh and colleagues from the Centers for Behavioral and Preventive Medicine at ...
Feb 4, 2013
0
0
(HealthDay)—The U.S. Food and Drug Administration late Friday approved three new medications to help people battle type 2 diabetes.
Jan 26, 2013
1
3
New drugs derived from components of a specific diet used by children with severe, drug-resistant epilepsy could offer a new treatment, according to research published today in the journal Neuropharmacology.
Nov 20, 2012
0
0
(Medical Xpress)—Recent reports about arsenic in rice have sparked a great deal of panic among U.S. consumers. However, the average American who eats a variety of whole grains doesn't need to stress about arsenic, according ...
Nov 15, 2012
0
0
Imagine a world where you could never dine away from home, wear makeup, smell of sweet perfumes or eat a large percentage of food on store shelves. According to allergists at the American College of Allergy, Asthma and Immunology ...
Nov 8, 2012
0
0
(AP)—The U.S. Food and Drug Administration may consider new standards for the levels of arsenic in rice as consumer groups are calling for federal guidance on how much of the carcinogen can be present in food.
Sep 19, 2012
0
0
(HealthDay) -- Non-nutritive sweeteners like Splenda, Equal and Sweet'N Low may have a role to play in maintaining or even losing weight, as long as people don't use them as an excuse to treat themselves later with high-calorie ...
Jul 9, 2012
0
0
For decades, neurologists have known that a diet high in fat and extremely low in carbohydrates can reduce epileptic seizures that resist drug therapy. But how the diet worked, and why, was a mystery—so much so that ...
May 23, 2012
1
0
(AP) -- Advisers to government health regulators on Thursday recommended that that they approve sales of what would be the first new prescription weight-loss drug in the U.S. in more than a decade, despite concerns over ...
May 10, 2012
0
0
US regulators will decide in July whether to approve Qnexa, the first obesity drug in more than a decade, extending the initial deadline by three months, the California-based drug-maker VIVUS said.
Apr 10, 2012
0
0
